Grifols leads the rises of the Ibex 35 with a rise of almost 8% after publishing its report by the CNMV. The blood products company led the rise of the ibex 35.
Grifols assured that it is committed to improving its transparency and expanding the breakdowns of its financial information following the regulator's recommendations. The supervisory body has referred to the financial information in some years of the period analyzed and in the presentation of alternative performance measures (APM), in particular the gross operating result and the debt/Ebitda ratio.